【レポートの概要（一部）】
1. Report Overview
1.1 Global Drug Delivery Technology Market Overview
1.2 Global Drug Delivery Technologies Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who Is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Drug Delivery Technology: An Introduction
2.1 Drug Delivery Technologies: Strategies to Improve Existing Drugs
2.2 The Global Drug Delivery Technology Market: Methods of Administration
2.2.1 The Biopharmaceutics Classification System and Using Better Tools to Model Drug Absorption
2.2.2 Sustained/Controlled Release Systems
2.2.3 Oral Drug Delivery: Swallowing Drugs to Reach a Target
2.2.4 Pulmonary Delivery: Delivered by Inhalation
2.2.5 Injection as a Route of Drug Delivery
2.2.6 Transdermal Delivery: More Patient-Friendly
2.2.7 Various Transmucosal Delivery Routes for Delivery
2.2.8 Ocular Delivery: Overcoming Unique Barriers
2.3 Regulation in the US
2.3.1 Regulation of Combination Products
2.3.2 FDA Guidelines for Injectors
2.4 Biopharmaceuticals
2.4.1 An Introduction to the Biological Drugs Market
2.4.2 Biologics: A Rising Drugs Market
2.4.3 Biologics with Associated Drug Delivery Technologies
2.4.4 Pegylated Interferons
2.4.5 Stiff Competition in Insulin Market Stimulating Investment in Drug Delivery Technologies
2.4.6 The Main Challenges Facing Biological Drug Delivery
2.5 Market Definition
3. Drug Delivery Technologies: Global Market, 2016-2026
3.1 The Global Drug Delivery Technology Market in 2015
3.2 The Global Drug Delivery Technology Market Forecast 2016-2026
3.3 Drug Delivery Technology: Drivers and Restraints 2016-2026
3.4 Biologics: A Driver for Growth in Drug Delivery Technologies
3.4.1 The Global Biological Drugs Market Forecast
3.4.2 Leading Classes of Biological Drugs
3.4.3 Monoclonal Antibodies: Largest Sector in Biologics
3.4.4 Human insulin: Leading the Therapeutic Protein Segment
3.4.5 Interferon Products for the Treatment of Hepatitis
3.5 Vaccines: Meeting the Unmet Needs
3.5.1 The Global Vaccines Market Forecast
4. Drug Delivery Technologies: Submarkets 2016-2026
4.1 The Global Drug Delivery Technology Market by Submarkets
4.2 How Will Segmental Market Shares Change to 2026?
4.3 Oral Drug Delivery Technology
4.3.1 Oral Drug Delivery Technology Market Forecast 2016-2026
4.3.2 Trends and Developments
4.3.2.1 Delivering APIs to the Colon
4.3.2.2 Google Investing in Robotic Pill
4.3.3 Oral Drug Delivery Technologies: Drivers and Restraints 2016-2026
4.4 Inhalable Drug Delivery Technology
4.4.1 Inhalable Drug Delivery Technology Market Forecast 2016-2026
4.4.2 Trends and Developments
4.4.2.1 Inhalable Liposomal Antibiotics to Penetrate Biofilms
4.4.2.2 Condensation Aerosol Generated by Heat
4.4.2.3 Is Inhaled Insulin Marketable?
4.4.3 Inhalable Drug Delivery Technologies: Drivers and Restraints 2016-2026
4.5 Injectable/Implantable Delivery Technology
4.5.1 Injectable/Implantable Delivery Technology Market Forecast 2016-2026
4.5.2 Trends and Developments
4.5.2.1 Ultrasound Activated Targeted Drug Delivery
4.5.2.2 Intradermal Vaccine Delivery
4.5.2.3 First Flu Vaccine Jet Injector Approved in the US
4.5.3 Injectable/Implantable Delivery Technologies: Drivers and Restraints 2016-2026
4.6 Transdermal Drug Delivery Technology
4.6.1 Transdermal Drug Delivery Technology Market Forecast 2016-2026
4.6.2 Trends and Developments
4.6.2.1 Iontophoretic Transdermal Patch for Migraine Approved in the US
4.6.2.2 Microneedle Patch for Vaccine Delivery
4.6.2.3 Ultrasonic Waveforms to Enlarge Skin Pores
4.7 Ocular Drug Delivery Technology
4.7.1 Ocular Drug Delivery Technology Market Forecast 2016-2026
4.7.2 Trends and Developments
4.7.2.1 Non-Surgical Microinjection to Retina and Choroid to be used for Gene Therapy
4.8 Nasal/Buccal Drug Delivery Technology
4.8.1 Nasal/Buccal Drug Delivery Technology Market Forecast 2015-2026
4.8.2 Trends and Developments
4.8.2.1 Nasal Spray with Live Attenuated Influenza Vaccine
4.8.2.2 Mucosal Vaccine Delivered through the Nose or Mouth
4.8.2.3 Buccal Insulin Spray in Clinical Trials
5. Drug Delivery Technologies: Leading National Markets, 2016-2026
5.1 Global Drug Delivery Technology Market: Regional Forecast 2016-2026
5.1.1 How Will Regional Market Shares Change to 2026?
5.2 US Drug Delivery Technology Market 2016-2026
5.2.1 US Drug Delivery Technology Market Forecast 2016-2026
5.2.2 Eli Lilly to Establish Drug Delivery Centre
5.3 EU5 Drug Delivery Technology Market 2016-2026
5.3.1 EU5 Drug Delivery Technology Market Forecast 2016-2026
5.3.2 EU5 Drug Delivery Technologies Market: CAGR (%) by Country, 2016-2026
5.3.3 EU5 Markets: Changing Market Shares by Country, 2016-2026
5.3.4 The German Drug Delivery Technology Market Forecast 2016-2026
5.3.5 The French Drug Delivery Technology Market Forecast 2016-2026
5.3.6 The UK Drug Delivery Technology Market Forecast 2016-2026
5.3.7 The Spanish Drug Delivery Technology Market Forecast 2016-2026
5.3.8 The Italian Drug Delivery Technology Market Forecast 2016-2026
5.4 Japanese Drug Delivery Technology Market 2016-2026
5.4.1 Japanese Drug Delivery Technology Market Forecast 2016-2026
5.4.2 The New Sakigake Designation System May Accelerate Innovative Drug Development
5.5 Chinese Drug Delivery Technology Market 2016-2026
5.5.1 Chinese Drug Delivery Technology Market Forecast 2016-2026
5.6 Indian Drug Delivery Technology Market 2016-2026
5.6.1 Indian Drug Delivery Technology Market Forecast 2016-2026
5.7 Brazilian Drug Delivery Technology Market 2016-2026
5.7.1 Brazilian Drug Delivery Technology Market Forecast 2016-2026
5.8 Russian Drug Delivery Technology Market 2016-2026
5.8.1 Russian Drug Delivery Technology Market Forecast 2016-2026
5.9 South Korean Drug Delivery Technology Market 2016-2026
5.9.1 South Korean Drug Delivery Technology Market Forecast 2016-2026
5.10 Mexican Drug Delivery Technology Market 2016-2026
5.10.1 Mexican Drug Delivery Technology Market Forecast 2016-2026
5.11 Rest of the World Drug Delivery Technology Market Forecast 2016-2026
6. Leading Companies in the Drug Delivery Technology Market, 2016-2026
6.1 Alkermes: Focused on Extended and Controlled Release
6.1.1 Alkermes: Drug Delivery Technology Portfolio
6.1.2 Long-Acting Injectables
6.1.3 Aristada vs. Abilify Maintena
6.1.4 Oral Controlled Release
6.1.4.1 Nanoparticle Technologies
6.1.5 Other Technologies
6.1.6 Alkermes: Product Portfolio
6.1.7 Alkermes: Pipeline Products 2016
6.1.8 Alkermes Recent Developments
6.1.8.1 Merger with Elan Drug Technologies
6.1.8.2 Alkermes: Future Outlook
6.1.9 Manufacturing Facility in Georgia Sold to Recro Pharma
6.2 3M: 50 Years of Drug Delivery Technology Development
6.2.1 3M: Drug Delivery Technology Portfolio
6.2.1.1 Oral and Topical Drug Delivery
6.2.1.2 MDI for Nasal and Inhalable Drugs
6.2.1.3 Transdermal patch Technology
6.2.1.4 Microneedle Technology
6.2.2 3M: Market Outlook
6.3 Skyepharma: Solutions for Inhalable, Oral, Topical and Injectable Drugs
6.3.1 Skyepharma: Drug Delivery Technology Portfolio
6.3.1.1 Inhalation Drug Delivery Technology
6.3.1.2 Oral Drug Delivery Technology
6.3.1.3 Injectable Drug Delivery Technology
6.3.1.4 Topical Drug Delivery Technology
6.3.2 Skyepharma: Pipeline Products 2016
6.3.3 Skyepharma: Market Outlook
6.4 Becton Dickinson and Company (BD): A History of Hypodermic Needles and Syringes
6.4.1 BD: Drug Delivery Technology Portfolio
6.4.1.1 Prefillable Syringe Systems
6.4.1.2 Self-Injection Systems
6.4.1.3 Pen Needles
6.4.1.4 Safety & Shielding Systems
6.4.2 BD: Future Outlook
6.4.3 New Infusion Set with BD FlowSmart Technology Cleared by FDA
6.4.4 BD Acquired Injection Safety Firms
6.5 Antares Pharma: Leading the Needle-Free Injector Market
6.5.1 Antares Pharma: Drug Delivery Product Portfolio
6.5.2 Antares Pharma: Future Outlook
6.5.3 Antares Pharma: Products in Development
6.6 pSivida: Targeting the Back of the Eye
6.6.1 pSivida: Drug Delivery Technology Portfolio
6.6.1.1 Durasert Technology
6.6.1.2 Tethadur Technology
6.6.2 pSivida: Pipeline Products 2016
6.6.3 pSidiva: Collaborations
6.6.4 pSivida: Future Outlook
6.7 Applied Pharma Research (APR)
6.7.1 APR’s Technology and Product Offerings
6.8 Ethypharm
6.8.1 Ethypharm’s Currently Marketed Products
6.9 Glycologic
6.9.1 Glycologic’s Drug Delivery Technologies
6.9.2 Glycologic’s Pipeline Developments
6.10 NanoPass Technologies
6.10.1 NanoPass Drug Delivery Products
6.10.1.1 Anti-aging Microdermabrasion
6.10.1.2 MicronJet Needle
7. Qualitative Analysis of the Drug Delivery Technology Market, 2016-2026
7.1 SWOT Analysis of the Drug Delivery Technology Market
7.2 Strengths
7.2.1 Increasing Competition and Patent Expiry in the Biologics Market
7.2.2 The Rise of Biosimilars
7.2.3 Increasing Global Diabetic Population
7.3 Weaknesses
7.3.1 Risk-Conscious Regulatory Bodies Will Make Approval Difficult
7.3.2 Companies Need to Develop a More Liberal Mindset
7.4 Opportunities
7.4.1 Nanotechnology: Innovations That Will Benefit Drug Delivery
7.4.2 Possible New Delivery Methods for Insulin
7.5 Threats
7.5.1 Increasing Specificity of Drug Development Poses Challenges to Speciality Drug Delivery Companies
7.5.2 Cost Effective Solutions May Not Be Available
8. Expert Opinions from Our Primary Research
8.1 Mr. Patrice Lewko, Vice President — Global Marketing & Innovation, Nemera
8.1.1 The Current state of the Drug Delivery Technologies Market
8.1.2 Key Pointers to Entering the Drug Delivery Technologies Market
8.1.3 The Key to Success for Novelia
8.1.4 Regions of Interest for Nemera and Prospects for Future Growth
8.1.5 Prospects for New Technologies
8.1.6 Major Challenges and Opportunities
8.2 Mr. Armand Amin, Manager — Systems Development, BioDuro
8.2.1 BioDuro Drug Delivery Technology Solutions
8.2.2 The Importance of Timing
8.2.3 The Current State of the Drug Delivery Technologies Market
8.2.4 Entering the Drug Delivery Technologies Market
8.2.5 New Technologies to Enter the Market
8.2.6 Future Challenges and Opportunities for Drug Delivery Technologies
8.2.7 Opportunities for Growth
9. Conclusions
9.1 The Global Drug Delivery Technologies Market in 2015
9.1.1 Current Leading Drug Delivery Technology Segments
9.1.2 Notable Drug Delivery Technology Companies
9.1.3 Leading Regional/National Markets
9.2 Global Drug Delivery Technology Market Forecast 2016-2026
9.3 The Future of the Drug Delivery Technology Market
9.3.1 Transdermal and Injectable Drug Delivery Technologies Set For High Growth
9.3.2 Biologics and Biosimilars to Drive Market Growth
10. Glossary
【レポート販売概要】
■ タイトル：薬物送達技術の世界市場予測2016-2026■ 英文：Drug Delivery Technologies Market Forecast 2016-2026
■ 発行日：2016年7月
■ 調査会社：visiongain
■ 商品コード：VGAIN81923
■ 調査対象地域：グローバル
- 次世代ネットワークOSS/BSS市場と展望2013-2018（Next Generation Network OSS/BSS Market and Forecast 2013-2018）NGN promises a high quality end-user experience. Telecommunications service providers expect the NGN framework to provide them with tools that would ensure customer loyalty. However, the path towards achieving the ideal NGN is fraught with formidable challenges. The most critical challenge confronting operators is optimizing their OSS and BSS platforms, systems, and processes. With research beginn …
- 世界の高性能コンピューティング・サーバー市場動向（2014-2018）TechNavio's analysts forecast the Global High-performance Computing Server market to grow at a CAGR of 7.78 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in Big Data. The Global High-performance Computing Server market has also been witnessing the emergence of cloud-based HPC solutions. However, the huge investment requirement could po …
- 整形外科用3Dプリンティング機器の世界市場2019-2023About this market 3D printing technologies are increasingly being used to develop patient-matched (or patient-specific) devices and surgical instrumentation by using a patient’s own medical imaging. The nature of additive layer manufacturing in 3D printing enables clinicians to fabricate customized implants that involve complex shapes and geometric features. 3D printing is also finding increasing …
- 自動車用エアフィルターの世界市場2017-2021ABSTRACTAbout Automotive Air Filter Air filter is an essential component of a heating, ventilation, and air conditioning (HVAC) system as it removes the particulate contaminants from the supplied air, which would be harmful to the occupants of the vehicle. It also forms an essential component of air moving devices, such as fan coils, terminal units, and air handlers, as it removes the dirt that ca …
- ラテラルフローイムノアッセイ（LFIA）ベース迅速試験の世界市場：用途別（感染症、妊娠と生殖能力、毒性学、その他）、技術別（競合アッセイ、サンドイッチアッセイ、多重検出アッセイ）、エンドユーザー別（病院＆クリニック、診断研究所、在宅ケア、その他）The global LFIA based rapid test market was valued at $4,725 million in 2018, and is projected to reach $8,494 million by 2026, registering a CAGR of 7.6% from 2019 to 2026. Lateral flow tests, or lateral flow immunochromatographic assays, are simple cellulose-based medical devices used to detect the presence of a target analyte in sample without use of specialized equipment where preliminary scre …
- バイオシミラーおよび後発生物製剤の世界市場動向・研究開発・売上予測：MAbs、融合蛋白質、インスリン、G-CSF、エリトロポエチン、インターフェロン、成長ホルモン、生殖ホルモンBiosimilars – Discover Revenue Predictions from 2016, Benefiting Your Authority Do you want to find sales potentials of biosimilar drugs? If so, our new analysis gives you revenue forecasts to 2026 at overall world market, therapeutic class and national level. See what is possible. For those therapies you explore sales data, R&D, opportunities and commercial prospects. Those emerging medicines hol …
- Allergic Conjunctivitis：グローバル臨床試験レビューH2, 2013Allergic Conjunctivitis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Allergic Conjunctivitis Global Clinical Trials Review, H2, 2013" provides data on the Allergic Conjunctivitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Allergic Conjunctivitis. It includes an overview of the trial numbers …
- 衛生器具の世界市場：浴槽・シャワー固定具・取付金具、シンク固定具・取付金具、トイレ固定具・取付金具MarketsandMarkets projects that the plumbing fixtures & fittings market size will grow from USD 74.72 Billion in 2015 to USD 102.07 Billion by 2021, at an estimated CAGR of 5.45%. The plumbing fixtures & fittings market is expected to witness high growth as a result of the rising urbanization, building renovations due to disasters and upgradation, large-scale investment in infrastructure & industr …
- エトキシレートの世界市場予測（～2021年）：アルコール、脂肪アミン、脂肪酸、メチル・エステル、グリセリド“Ethoxylates market to reach USD 12.37 billion by 2021”The global ethoxylates market was valued at USD 10.16 billion in 2015 and is projected to reach USD 12.37 billion by 2021, at a CAGR of 3.33% from 2016 to 2021. The growing demand from major end-use industries such as household & personal care, and pharmaceutical is expected to drive the market in the future. The harmful environmental effects …
- 自動車トランスミッションの世界市場：MT、AT、デュアル・クラッチ・トランスミッション（DCT）、無段変速機（CVT）Transmission systems transfer the required amount of torque from the engine to the driven wheels in a vehicle through multiple gear ratios. It utilizes a clutch, which can be operated either manually or automatically, and gears to provide an optimum delivery of the power generated from an engine. The power transmission differs according to the speed of the vehicle through different ratios. It util …
- Pacific Rubiales Energy Corp.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Pacific Rubiales Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Pacific Rubiales Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an …
- 医療装置用ラベリングの世界市場展望2017-2026According to Stratistics MRC, the Global Medical Device Labeling market accounted for $699.91 million in 2017 and is expected to reach $1,375.98 million by 2026 growing at a CAGR of 7.8% during the forecast period. Increasing implementation of FDA standards for patient safety, the introduction of new medical devices and flourishing healthcare and pharmaceutical industries are some key factors infl …
- 世界のSaaS市場動向（2012-2016）TechNavio's analysts forecast the Global Software as a Service market to grow at a CAGR of 29.8 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for reduced total cost of ownership. The Global Software as a Service market has also been witnessing an increased demand from the Government sector. However, concerns with respect to data security c …
- 皮なめし機械の世界市場2016-2020About Tanning Tanning is an integral part of the entire leather production process. It is the conversion of the protein of raw skin or hide into a material that is stable. The process ensures that the hide or converted material does not decompose and is suitable for end-user applications. Technavio’s analysts forecast the global leather tanning machinery market to grow at a CAGR of 3.99% during th …
- 転移性前立腺がん(Metastatic Prostate Cancer)の治療薬パイプライン動向（2015年上半期版）Metastatic Prostate Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Metastatic Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Prostate Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Prostate Cancer, complete with comparative analysis at various stages, therapeutics …
